Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous vs intrathecal dexamethasone for pain and postoperative nausea/vomiting after cesarean section
IRCT20141001019359N16Phase 3Completed
- Sponsor
- North Khorasan University of Medical Sciences
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by North Khorasan University of Medical Sciences. Primary endpoints: Postoperative pain intensity and Incidence of postoperative nausea and vomiting. Started Dec 2022; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20141001019359N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141001019359N16.